Evidence map›Paper›PMID 42544822›Full record

ArticleSynapse (New York, N.Y.)2026

Increased Binding of [

Jogeshwar Mukherjee, Fariha Karim, Allyson Ngo, Christopher Liang, Geidy E Serrano, Thomas G Beach

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Synapse (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Jogeshwar MukherjeePreclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, California, USA.
Fariha KarimPreclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, California, USA.
Allyson NgoPreclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, California, USA.
Christopher LiangPreclinical Imaging, Department of Radiological Sciences, University of California-Irvine, Irvine, California, USA.
Geidy E SerranoBanner Sun Health Research Institute, Sun City, Arizona, USA.
Thomas G BeachBanner Sun Health Research Institute, Sun City, Arizona, USA.

Funding

Novel Tau-Targeted Radiohalogenated Agents for Alzheimer's DiseaseR01AG077700 · UNIVERSITY OF CALIFORNIA-IRVINE · 2025 to 2025
$698k
NIA NIH HHS R01 AG029479NIA NIH HHS R01 AG077700NIH HHS AG029479NIH HHS AG077700
6 · The paper itself

Abstract

Non-motor symptoms in Parkinson's disease (PD) may be influenced by the α4β2* subtype of nicotinic acetylcholine receptors (nAChRs) present in the hippocampus (HP) and subiculum (SUB). To continue efforts in positron emission tomography (PET) diagnostics for PD, autoradiographic [

Indexed as

HippocampusParkinson DiseaseReceptors, NicotinicAgedAged, 80 and overFemaleFluorine RadioisotopesHumansMaleMiddle AgedPositron-Emission TomographyPyridinesPyrrolesRadiopharmaceuticalsFluorine Radioisotopesnicotinic receptor alpha4beta2nifenePyridinesPyrrolesRadiopharmaceuticalsReceptors, NicotinicLewy bodiesneurodegenerationnifenepositron emission tomography (PET)α‐synucleinopathy

Identifiers

PMID42544822
PMCPMC13430585

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.